Delivery Order SPE2DR25D3501-SPE2DR26FM0DN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,314.68 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (8-count package) under a firm fixed-price contract. The award was made on October 21, 2025, with an ultimate completion date of October 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and is issued as a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.91 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 MCG vaginal inserts (8-count package). This is a firm fixed-price delivery order with no set-aside designation, issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,093.79 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,004.41 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 MCG Vaginal Insert (8 count). The award, issued on September 12, 2025, represents a firm fixed-price contract with an ultimate completion date of September 15, 2025. This is a non-set-aside competitive award, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,004.48 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 microgram vaginal inserts (18-count package) on November 6, 2025, with completion expected by November 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,444.10 for Yuvafem 10 microgram vaginal insert (18 units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's extensive pharmaceutical supply relationship with DLA and carries no set-aside designation. The product will be performed and delivered from...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Yuvafem 10 micrograms vaginal inserts (18 units) under a firm fixed-price contract valued at $1,741.75. This is a non-set-aside competitive award with an ultimate completion date of August 12, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,702.11 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (8-count packages) on December 22, 2025, with a completion date of December 23, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.56 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing Indefinite...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM0DNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 MCG vaginal inserts (18-count) under a firm fixed-price contract valued at $1,521.90. The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, leveraging its extensive portfolio as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/7/25 |